Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ketamine for Sedation in Severe Traumatic Brain Injury

NCT06429657 is registered in ClinicalTrials.gov with Henry M. Jackson Foundation for the Advancement of Military Medicine as lead sponsor.

NCT NCT06429657
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06429657 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ketamine for Sedation in Severe Traumatic Brain Injury
Lead sponsor
Henry M. Jackson Foundation for the Advancement of Military Medicine
Phase
Phase 4
Overall status
Suspended
Start date
September 23, 2024
Completion date
June 30, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intracranial hemorrhage, hypertensive, intracranial hypertension, severe traumatic brain injury